Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6–30.
2. Markman M, Hoskins WJ: Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population. J Clin Oncol 1992, 10:513–514.
3. Eisenhauer EA, Vermorken JB, Glabbeke M: Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients. Ann Oncol 1997, 8:963–968.
4. Bolis G, Scarfone G, Villa A, et al.: A randomized study in recurrent ovarian cancer comparing the efficacy of single agent vs combination chemotherapy according to time to relapse [abstract]. Proc ASCO 1996, 15:279.
5. Bolis G, Parazzini F, Scarfone G, et al.: Paclitaxel vs epidoxorubicin plus paclitaxel as second-line therapy for platinum-refractory and resistant ovarian cancer. Gynecol Oncol 1999, 72:60–64.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献